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Abstract: UNLABELLED Pheochromocytomas (PCC) and paraganglioma (PGL) are rare neuroen-
docrine tumors arising from chromaffin cells of the neural crest. Mutations in the RET-proto-oncogene are
associated with sporadic pheochromocytoma, familial or sporadic medullary thyroid carcinoma (MTC)
and multiple endocrine neoplasia type 2. In the past, only few cases of pigmented PCCs, PGLs, and
one case of pigmented MTC have been reported in the literature. Herein, we present the case of a 77-
year old woman with a history of Tako-tsubo-cardiomyopathy and laboratory, as well as radiological,
high suspicion of pheochromocytoma, who underwent left-sided adrenalectomy. The 3 cm tumor, which
was located on the upper pole of the left adrenal, appeared highly pigmented with dark red to black
color. Histologic examinations revealed highly pleomorphic cells with bizarre, huge hyperchromatic nu-
clei, that immunohistochemically were positive for chromogranin A and synaptophysin, focally positive
for HMB45 and negative for melan A. These clinical and pathological features led to the diagnosis of
the rare variant of a melanotic ’black’ pheochromocytoma. In our case a somatic RET mutation in exon
16 (RET c.2753T>C, p.Met918Thy) was detected by targeted next generation sequencing. In summary,
this case represents a rare variant of catecholamine-producing tumor with distinct histological features.
A potential relationship between the phenotype, the cellular origin and the genetic alterations is dis-
cussed. LEARNING POINTS Pheochromocytoma is a rare neuroendocrine tumor.Pigmentation is seen
in several types of tumors arising from the neural crest. The macroscopic black aspect can mislead to the
diagnosis of a metastasis deriving from a malignant melanoma.RET mutation are seen in catecholamine
and non-catecholamine producing tumors of the same cellular origin.
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Pheochromocytomas (PCC) and paraganglioma (PGL) are rare neuroendocrine tumors arising from chromaffin cells of the
neural crest. Mutations in the RET-proto-oncogene are associated with sporadic pheochromocytoma, familial or sporadic
medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2. In the past, only few cases of pigmented PCCs,
PGLs, and one case of pigmented MTC have been reported in the literature. Herein, we present the case of a 77-year old
woman with a history of Tako-tsubo-cardiomyopathy and laboratory, as well as radiological, high suspicion of
pheochromocytoma, who underwent left-sided adrenalectomy. The 3 cm tumor, which was located on the upper pole of the
left adrenal, appeared highly pigmented with dark red to black color. Histologic examinations revealed highly pleomorphic
cells with bizarre, huge hyperchromatic nuclei, that immunohistochemically were positive for chromogranin A and
synaptophysin, focally positive for HMB45 and negative for melan A. These clinical and pathological features led to the
diagnosis of the rare variant of a melanotic ‘black’ pheochromocytoma. In our case a somatic RET mutation in exon 16
(RETc.2753TOC, p.Met918Thy) was detected by targeted next generation sequencing. In summary, this case represents a rare
variant of catecholamine-producing tumor with distinct histological features. A potential relationship between the
phenotype, the cellular origin and the genetic alterations is discussed.
Learning points:
† Pheochromocytoma is a rare neuroendocrine tumor.
† Pigmentation is seen in several types of tumors arising from the neural crest. The macroscopic black aspect can
mislead to the diagnosis of a metastasis deriving from a malignant melanoma.
† RET mutation are seen in catecholamine and non-catecholamine producing tumors of the same cellular origin.
Background
This case represents a rare variant of catecholamine-
producing tumor with distinct histological features. A
potential relationship between the phenotype, the cellular
origin and the genetic alterations is discussed.
Case presentation
A 77-year-old patient with a history of arterial hyperten-
sion, intermittent atrial fibrillation and an episode of
Takot-tsubo-cardiomyopathy presented for pre-surgical
evaluation of suspected catecholamine excess.
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Investigation
Repeated laboratory examinations documented elevated
plasma and urine metanephrine (urine metanephrine
6205.88 mg/24 h (!699.66 mg/24 h), normethanephrine
4013.1 mg/24 h (!1698.06 mg/24 h) andplasmametaneph-
rine 1460.16 pmol/l (!465.3 pmol/l), normetanephrine
1116.72 pmol/l (!982.8 pmol/l)). A combined 18F-DOPA-
PET/CT scan revealed presence of a clearly DOPA-positive
(SUVmax 7,8) lesion considered to be arising from the left
adrenal gland, measuring 3.0!3.3 cm (Fig. 1).
Pathologic findings
The resected tumor measured 3.5!3.2!2.2 cm and
weighed 37g including adjacent adrenal tissue. The
tumor was relatively well demarcated with macro-
scopically red to black color, surrounded by a thin
golden-yellow rim representing the preexistent adrenal
cortex. Histological slides showed compact groups of cells,
partly with huge bizarre, hyperchromatic cell nuclei, and
pigment inclusions within the granular cytoplasm.
Because of the macroscopical appearance there was initial
suspicion of malignant melanoma but in consideration
of the clinically and radiologically clear indication of
pheochromocytoma, additional immunohistochemical
analyses were performed. Tumor cells showed an intense
expression of chromogranin A and synaptophysin, S100
was positive only in sustentacular cells (Fig. 2A, B, C
and D). HMB45, a marker of melanosomes showed focal
positive cytoplasmic staining (Fig. 2F) and Melan A was
negative (Fig. 2E). These features led to the final diagnosis
of a melanotic pheochromocytoma (Fig. 3).
Targeted next generation sequencing including
EPAS1, FH, HRAS, KIF1B, MAX, MDH2, MEN1, NF1, RET,
SDHA, SDHAF1, SDHAF2, SDHB, SDHC, SDHD, TMEM127
and VHL was done on the tumor DNA, which revealed a
somatic RET mutation in exon 16 (RET c.2753TOC,
p.Met918Thy), further validated by Sanger sequencing.
An underlying MEN2 syndrome was excluded by sequen-
cing the germline DNA.
Treatment
The patient was treated preoperatively with alpha block-
ade and underwent uneventful left-sided laparoscopic
adrenalectomy. After a short recovery period the patient
was discharged from the hospital without need for
antihypertensive medication.
Outcome and follow-up
Follow-up examinations 3 and 6 month after surgery
revealed normalization of plasma catecholamines.
Figure 1
Combined DOPA-PET/CT scan of the abdomen showing an intensively
DOPA-positive lesion on the upper left kidney pole.
Figure 2
The hematoxylin eosin staining (A) shows highly vascularized tumor tissue,
composed of highly pleomorphic, basophilic tumor cells. The positive
staining of chromogranin A (B) and synaptophysin (C) of the tumor cells
and the presence of S100 positive cells (D) surrounding the tumor cells,
confirms this tumor is a pheochromocytoma. Melan-A staining is negative
in the tumor cells (E), while the remaining cortex stains positive. HMB45,
a marker for melanosomes, shows focal positive cytoplasmic staining (F).
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Following current guideline suggestions yearly follow-up
examinations were recommended (1).
The patient was enrolled into the registry and biobank
of the European Network for the Study of Adrenal Tumors
(www.ensat.org) upon written informed consent.
Discussion
Similar to other reports in the literature the black
pigmentation of the tumor first led to the suspicion of a
metastasis deriving from a malignant melanoma. In fact,
black pheochromocytomas (PCC) are very rarely found.
In a well defined sub-cohort of 766 PCC/paraganglioma
(PGL) patients registered in the ENSAT registry (from
Munich, Rotterdam, Madrid, Dresden and Paris) this is the
first reported case of a ‘black’ pheochromocytoma. In the
literature, only 18 cases of pigmented PGL and onemacro-
and 11 microscopically pigmented pheochromocytomas
have been reported (Table 1), which emphasizes the
rareness of this finding. However, several cases of
pigmented tumors, (2), (3) among which neuroblastomas,
schwannomas or adrenocortical adenoma, had been
described in the past. Ikeda et al. (4) reported a case of an
medullary thyroid carcinoma (MTC) with a PGL-like
pattern and melatonin production. The tumor showed
the PGL-typical ‘sustentacular cells’ as well as pigmented
dendritic cells. Genetic analysis unfortunately is not
available in this case.
Reported histopathological results regarding the pig-
ment differed, but in most cases lipofuscin, true melanin
and neuromelanin were found (5). In our case, the positive
Figure 3
Macroscopic aspect of the resected tumor (following paraffin embedding).







Landas et al. (7) 6 6
Chetty et al. (8) 3 3
Langer et al. (9) 1 1
Bellezza et al. (10) 1 1
Handa et al. (11) 1 1
Present case 1 1
Pigmented paraganglioma
Stout (1935) 1 Ganglion nodosum NR
Tavassoli (12) 2 Uterus NR
Paulus et al. (13) 1 Orbit NR
Hofmann et al. (14) 1 Posterior mediastinum NR
Küchemann (15) 1 Retroperitoneum NR




Lack et al. (5) 1 Retroperitoneum NR
Mikolaenko et al. (17) 1 Heart NR
Dundr et al. (18) 1 Urinary bladder NR
Reddy et al. (19) 1 Vagal trunk NR
Miraldi et al. (20) 1 Heart NR
Gonnella et al. (21) 1 Heart NR
Petramala et al. (22) 1 Heart SDHB
Zhao et al. (23) 1 Kidney NR
NR, not reported.
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HMB45 staining indicates that the pigment results from
the presence of melanosomes in at least some of the tumor
cells. While true melanin is a pigment produced by
melanocytes from L-DOPA, neuromelanin and lipofuscin
are byproducts of the macro-autophagy pathway and are
associated with breakdown of mitochondria (lipofuscin)
and metabolism of catecholamines (neuromelanin) (5).
Neuromelanin can also be found in neurons of the
substantia nigra. Sulzer et al. (6) have shown that L-DOPA
induced elevation of cytosolic dopamine is responsible
for extended neuromelanin biosynthesis. Thus, neuro-
melanin and lipofuscin are probably related to excessive
catecholamine oxidation. It is suggestive that the
tumor cells in pheochromocytoma would contain neuro-
melanin rather than melanin, also because they possess
the enzymes (L-DOPA) to produce it. However, a clear
distinction between melanin and neuromelanin cannot
be drawn by immunohistochemical staining procedures
alone.
The somatic RET mutation found in our case is of
interest as also non-catecholamine producing but MEN2
associated tumors such as MTC have been reported to
occur as hyperpigmented. The rareness of this association
clearly indicates that RET mutations are not sufficient to
cause a hyperpigmentation phenotype. However, it is of
interest, that melanocytes, C-cells and adrenal medullary
cells share common embryogenetic origins from the
neural crest. This common ancestry could be the basis
for shared morphological features during tumor develop-
ment. However, as pigmentation is not an usual feature
in non-melanotic tumors, other molecular factors seem to
be necessary to induce this particular phenotype.
Summary
A ‘black,’, hyperpigmented, adrenal pheochromocytoma
is a very rare variant of a catecholamine producing tumor
which in the presented case was associated with the
presence of melanosomes in tumor cells and the presence
of somatic RET mutation. As pigmentation has also been
described in non-catecholamine-producing tumor cells
originating from the neural crest, such as MTC, common
mechanisms for pigmentation in these tumor entities
could be considered.
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